AstraZeneca will pay $425 million to settle lawsuits on behalf of consumers who suffered kidney injuries while using its heartburn medications Nexium and Prilosec. AstraZeneca in a statement said ...

Oct. 3 (UPI) --Multinational pharmaceutical maker AstraZeneca said Tuesday it will pay $425 million to settle lawsuits from people who experienced kidney damage from the company's heartburn ...

Emergent BioSolutions Inc. has agreed to pay $40 million to settle a lawsuit brought by shareholders who had accused it of ...

Common medicines used to treat conditions including heartburn, reflux, indigestion and stomach ulcers may be the subject of a ...

An AstraZeneca Plc unit settled a federal patent-infringement lawsuit with a Samsung Biologics Co. subsidiary after failing to block its biosimilar version of the $500,000-per-patient drug Soliris.

Walgreens was accused of submitting false payment claims to federal health care programs for prescriptions that were ...

Drugs giant AstraZeneca has agreed to settle a raft of legal claims over ... GSK said in June that it had settled a lawsuit relating to Zantac – known chemically as ranitidine – and that ...

AstraZeneca unit and Samsung Bioepis resolve their patent dispute over a biosimilar | Settlement follows FDA approval for the ...

Drugs giant AstraZeneca has agreed to settle a raft of legal claims over its heartburn ... GSK said in June that it had settled a lawsuit relating to Zantac – known chemically as ranitidine – and that ...